John Rothman

705 total citations
13 papers, 568 citations indexed

About

John Rothman is a scholar working on Biotechnology, Immunology and Oncology. According to data from OpenAlex, John Rothman has authored 13 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biotechnology, 6 papers in Immunology and 3 papers in Oncology. Recurrent topics in John Rothman's work include Cancer Research and Treatments (7 papers), Immunotherapy and Immune Responses (6 papers) and Listeria monocytogenes in Food Safety (4 papers). John Rothman is often cited by papers focused on Cancer Research and Treatments (7 papers), Immunotherapy and Immune Responses (6 papers) and Listeria monocytogenes in Food Safety (4 papers). John Rothman collaborates with scholars based in United States, Malaysia and Serbia. John Rothman's co-authors include Siniša Radulović, Paulo Maciag, Anu Wallecha, Reshma Singh, Yvonne Paterson, Mikayel Mkrtichyan, Peter Makhov, Vladimir Kolenko, Konstantin Golovine and Paul L. Crispen and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

John Rothman

13 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Rothman United States 9 260 189 184 125 104 13 568
Amalie Grenov Israel 8 134 0.5× 218 1.2× 95 0.5× 86 0.7× 497 4.8× 8 787
Barbara Potempa United States 19 170 0.7× 105 0.6× 49 0.3× 77 0.6× 302 2.9× 39 1.1k
Demi Sandel United States 4 294 1.1× 339 1.8× 94 0.5× 51 0.4× 455 4.4× 5 837
Xilai Ding China 11 523 2.0× 106 0.6× 23 0.1× 303 2.4× 169 1.6× 18 876
Djenet Bousbaine United States 11 148 0.6× 97 0.5× 66 0.4× 94 0.8× 272 2.6× 15 589
Rose Parkinson United States 13 461 1.8× 190 1.0× 40 0.2× 142 1.1× 203 2.0× 34 815
Marc Mansour Canada 16 470 1.8× 240 1.3× 25 0.1× 113 0.9× 239 2.3× 37 703
Cindrilla Chumduri Germany 12 132 0.5× 125 0.7× 40 0.2× 164 1.3× 255 2.5× 21 584
Philipp Schlaermann Germany 6 175 0.7× 115 0.6× 24 0.1× 44 0.4× 172 1.7× 7 517
M. Cardinali United States 15 186 0.7× 204 1.1× 44 0.2× 124 1.0× 323 3.1× 25 783

Countries citing papers authored by John Rothman

Since Specialization
Citations

This map shows the geographic impact of John Rothman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Rothman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Rothman more than expected).

Fields of papers citing papers by John Rothman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Rothman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Rothman. The network helps show where John Rothman may publish in the future.

Co-authorship network of co-authors of John Rothman

This figure shows the co-authorship network connecting the top 25 collaborators of John Rothman. A scholar is included among the top collaborators of John Rothman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Rothman. John Rothman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mkrtichyan, Mikayel, Rasha Abu Eid, Anu Wallecha, et al.. (2013). Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy. Journal for ImmunoTherapy of Cancer. 1(1). 15–15. 56 indexed citations
2.
Rothman, John & Yvonne Paterson. (2013). Live-attenuatedListeria-based immunotherapy. Expert Review of Vaccines. 12(5). 493–504. 36 indexed citations
3.
Wallecha, Anu, et al.. (2012). Lm-LLO-Based Immunotherapies and HPV-Associated Disease. Journal of Oncology. 2012. 1–10. 42 indexed citations
4.
Hannan, Raquibul, Huagang Zhang, Anu Wallecha, et al.. (2012). Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancer. Cancer Immunology Immunotherapy. 61(12). 2227–2238. 31 indexed citations
5.
Wallecha, Anu, et al.. (2012). Immune Response and Immunotherapy: Live Attenuated Listeria monocytogenes (Lm)-LLO Immunotherapy for the Treatment of Prostate Cancer. Current Cancer Therapy Reviews. 8(4). 254–263. 1 indexed citations
6.
Rothman, John. (2010). The use of a live listeria vaccine in the treatment of cancer.. Journal of Clinical Oncology. 28(15_suppl). e15542–e15542. 1 indexed citations
7.
Maciag, Paulo, Siniša Radulović, & John Rothman. (2009). The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix. Vaccine. 27(30). 3975–3983. 259 indexed citations
8.
Radulović, Siniša, Mirjana Branković-Magić, Emina Mališić, et al.. (2009). Therapeutic cancer vaccines in cervical cancer: phase I study of Lovaxin-C.. PubMed. 14 Suppl 1. S165–8. 23 indexed citations
9.
Makhov, Peter, Konstantin Golovine, Robert G. Uzzo, et al.. (2008). Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Cell Death and Differentiation. 15(11). 1745–1751. 62 indexed citations
10.
Rothman, John. (2008). Abstract 225: The first use of a live listeria cancer vaccine in man. Cancer Research. 68(9_Supplement). 225–225. 1 indexed citations
11.
Sørensen, Henrik Toft, Lars Pedersen, Bente Mertz Nørgård, Kirsten Fonager, & John Rothman. (2001). Does month of birth affect risk of Crohn's disease in childhood and adolescence?. BMJ Case Reports. 323. 2 indexed citations
12.
Volberding, Paul A., et al.. (1984). ALPHA INTERFERON THERAPY OF KAPOSRS SARCOMA IN AIDS. Annals of the New York Academy of Sciences. 437(1). 439–446. 24 indexed citations
13.
Ahlgren, James D., et al.. (1984). A phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancer. Cancer. 54(10). 2257–2261. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026